July 20, 2017
Excluding mums-to-be from clinical studies is unfair and could be potentially harmful, researchers have said.
Pregnant women are often ruled out of participating in clinical trials because they’re classified as a “vulnerable” group, and this creates a knowledge void around the impact of drugs taken during pregnancy and “unfairly excludes” them from taking part in clinical studies, concluded researchers writing in the ‘Journal of Medical Ethics’.
“There is a desperate need to shift the paradigm to protect pregnant women through research, not just from research,” the researchers wrote.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.